Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KalVista Pharmaceuticals (KALV) Net Margin (2016 - 2020)

Historic Net Margin for KalVista Pharmaceuticals (KALV) over the last 7 years, with Q2 2020 value amounting to 224.74%.

  • KalVista Pharmaceuticals' Net Margin rose 1470700.0% to 224.74% in Q2 2020 from the same period last year, while for Jan 2021 it was 224.74%, marking a year-over-year increase of 1228600.0%. This contributed to the annual value of 3171.17% for FY2025, which is 34244500.0% up from last year.
  • As of Q2 2020, KalVista Pharmaceuticals' Net Margin stood at 224.74%, which was up 1470700.0% from 783.26% recorded in Q1 2020.
  • In the past 5 years, KalVista Pharmaceuticals' Net Margin registered a high of 13.57% during Q2 2018, and its lowest value of 94342.86% during Q1 2016.
  • Its 5-year average for Net Margin is 6583.21%, with a median of 371.8% in 2019.
  • Per our database at Business Quant, KalVista Pharmaceuticals' Net Margin plummeted by -202857100bps in 2016 and then skyrocketed by 49472100bps in 2018.
  • Over the past 5 years, KalVista Pharmaceuticals' Net Margin (Quarter) stood at 2152.79% in 2016, then skyrocketed by 79bps to 442.41% in 2017, then soared by 81bps to 83.85% in 2018, then tumbled by -167bps to 224.08% in 2019, then fell by 0bps to 224.74% in 2020.
  • Its Net Margin stands at 224.74% for Q2 2020, versus 783.26% for Q1 2020 and 224.08% for Q4 2019.